Diabetes complications

Long‐term effects of coronavirus disease 2019 on diabetes complications and mortality in people with diabetes: Two cohorts in the UK and Hong Kong

Diabetes Obes MetabPublished Matched cohort study

Authors' conclusion

COVID-19 infection is associated with long-term increased risks of diabetes complications (especially cardiovascular complications, and mortality) in people with diabetes. Monitoring for signs/symptoms of developing these long-term complications post-COVID-19 infection in the infected patient population of people with diabetes may be beneficial in minimizing their morbidity and mortality.

Study context

Population
People with diabetes, UK Biobank and Hong Kong electronic health recordsmatched cohorts
Participants
2,456 / 41,801 / 80,546 / 391,849
Exposure
COVID-19 infection vs no COVID-19 in people with diabetes
  • Exposed (UKB)n = 2,456
  • Unexposed (UKB)n = 41,801reference
  • Exposed (HK)n = 80,546
  • Unexposed (HK)n = 391,849reference
Outcome
Multi-organ disease complications and all-cause mortality after 21 days of diagnosis (Cox regression)
Follow-up
Up to 18 months (UKB); up to 28 months (HK)
Methodological detailstwo cohorts (UK Biobank and Hong Kong), matched on age and sex, Inverse Probability Treatment Weighting
  • Two cohorts (UK Biobank and Hong Kong)
  • Matched on age and sex
  • Inverse Probability Treatment Weighting

Main finding

As reported in the abstract

CHD, HR (UKB)
1.6 (95% CI 1.0, 2.4)
CHD, HR (HK)
1.2 (95% CI 1.0, 1.5)
Stroke, HR (UKB)
2.0 (95% CI 1.1, 3.6)
Stroke, HR (HK)
1.5 (95% CI 1.3, 1.8)
End stage renal disease, HR (UKB)
2.1 (95% CI 1.1, 4.0)
End stage renal disease, HR (HK)
1.2 (95% CI 1.1, 1.4)
All-cause mortality, HR (UKB)
4.6 (95% CI 3.8, 5.5)
All-cause mortality, HR (HK)
2.6 (95% CI 2.5, 2.8)

Observational data: associations, not effects.

Original publication

Long‐term effects of coronavirus disease 2019 on diabetes complications and mortality in people with diabetes: Two cohorts in the UK and Hong Kong. Diabetes Obes Metab. Published 21 September 2023. doi:10.1111/dom.15279

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.